You are here: Home » Markets » News
Business Standard

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

The Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent higher led by Infosys and NIIT Tech

Topics
Market Wrap  |  Sensex  |  Nifty

SI Reporter  |  New Delhi 

The benchmark indices settled 0.5 per cent higher on Monday led by market heavyweights Reliance Industries, Sun Pharma and select information technology (IT) and private bank stocks. The S&P BSE Sensex ended at 36,579, up 192 points or 0.53 per cent, while the broader Nifty50 index settled at 10,962, up 55 points or 0.50 per cent. Among sectoral indices, the Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent led by Infosys and NIIT Technologies. In the ...

MONTHLY STAR

Business Standard Digital

Business Standard Digital Monthly Subscription
149.00  
subscribe
Complete access to the premium product
Convenient - Pay as you go
Pay using Master/Visa Credit Card & ICICI VISA Debit Card
Auto renewed (subject to your card issuer's permission)
Cancel any time in the future
Requires personal information

What you get?

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all the content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

NOTE :

  • The product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the email with the cancellation request to assist@bsmail.in. Include your contact number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART MONTHLY

Business Standard Digital

Business Standard Digital - 12 Months
1499.00
subscribe
Get 12 months of Business Standard digital access
Single Seamless Sign-up to Business Standard Digital
Convenient - Once a year payment
Pay using an instrument of your choice - Credit/Debit Cards, Net Banking, Payment Wallets accepted
Exclusive Invite to select Business Standard events

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.

NOTE :

  • This product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Top sectoral gainers and losers on NSE

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

S&P BSE Sensex: Top gainers and losers

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Market at close The S&P BSE Sensex ended at 36,579, up 192 points or 0.53 per cent, while the broader Nifty50 index settled at 10,962, up 55 points or 0.50 per cent.

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Reliance Industries gains 9% in two days post December quarter results Shares of Reliance Industries (RIL) were quoting higher by 4.4 per cent at Rs 1,237 apiece at the fag-end of the trading session on Monday , gaining nine per cent in the past two trading days on BSE, after the company reported a better-than-expected consolidated net profit of Rs 10,251 crore in October-December quarter (Q3FY19). The company had logged profit of Rs 9,420 crore in the year-ago quarter. READ MORE

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Union Bank declines 5% post Q3 results announcement Shares of Union Bank plunged as much as 5 per cent in the intra-day deals on Monday after the lender reported net profit of Rs 153.2 crore for October-December quarter of FY19. The bank had posted loss of Rs 1,250 crore in the year-ago period.   Percentage wise, net NPAs came in at 8.27 per cent against 8.42 per cent in the September quarter. In the year-ago quarter, numbers stood at 6.96 per cent. Net interest income (NII) fell 2.1 per cent YoY. READ MORE

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

NEWS ALERT Hind Zinc Q3FY19 net profit at Rs 2,211 crores vs Rs 2,298 in Q3FY18

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Top gainers on BSE500 COMPANY PRICE() CHG() CHG(%) VOLUME SPARC 168.15 19.75 13.31 1307057 ITI 111.80 7.40 7.09 854733 TAKE SOLUTIONS 162.95 8.40 5.44 54518 TIME TECHNOPLAST 106.00 5.30 5.26 56458 UNITED BREWERIES 1479.25 66.00 4.67 40201 » More on Top Gainers

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

LIC completes the acquisition of 51% controlling stake in IDBI Bank IDBI Bank Monday said insurance behemoth LIC has completed acquisition of 51 per cent controlling stake in the bank, making it the lender's majority shareholder. "The deal, conceptualised in June 2018, is envisaged as a win-win situation for both IDBI Bank and LIC with an opportunity to create enormous value for shareholders, customers & employees of both entities through mutual synergies," IDBI Bank said in a BSE filing. Read more  

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Earnings Impact

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

NEWS ALERT | Union Bank reports net profit at Rs 153.2 cr vs Rs 139.03 cr on QoQ

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

Goldman Sachs expects RBI to cut rates by a quarter percentage point in Feb Goldman Sachs Group Inc. expects India’s central bank to cut interest rates by a quarter percentage point in February, the latest to add its voice to a chorus of calls for monetary policy easing. The Wall Street bank said lower inflation projections, and expectations of a slower pace of U.S. policy rate hikes prompted it to shift its call from a previous forecast of no change in February. Read more A view of the Goldman Sachs stall on the floor of the New York Stock Exchange in New York (Photo: Reuters)

First Published: Mon, January 21 2019. 08:16 IST
RECOMMENDED FOR YOU

MARKET WRAP: Sensex up 192 pts, Nifty ends at 10,962 led by RIL, Sun Pharma

The Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent higher led by Infosys and NIIT Tech

The benchmark indices settled 0.5 per cent higher on Monday led by market heavyweights Reliance Industries, Sun Pharma and select information technology (IT) and private bank stocks. The S&P BSE Sensex ended at 36,579, up 192 points or 0.53 per cent, while the broader Nifty50 index settled at 10,962, up 55 points or 0.50 per cent. Among sectoral indices, the Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent led by Infosys and NIIT Technologies. In the ...

image
Business Standard
177 22
.